Nicotine withdrawal and agitation in ventilated critically ill patients

Olivier Lucidarme, Amélie Seguin, Cédric Daubin, Michel Ramakers, Nicolas Terzi, Patrice Beck, Pierre Charbonneau, Damien du Cheyron, Olivier Lucidarme, Amélie Seguin, Cédric Daubin, Michel Ramakers, Nicolas Terzi, Patrice Beck, Pierre Charbonneau, Damien du Cheyron

Abstract

Introduction: Smoking is highly addictive, and nicotine abstinence is associated with withdrawal syndrome in hospitalized patients. In this study, we aimed to evaluate the impact of sudden nicotine abstinence on the development of agitation and delirium, and on morbidities and outcomes in critically ill patients who required respiratory support, either noninvasive ventilation or intubation, and mechanical ventilation.

Methods: We conducted a prospective, observational study in two intensive care units (ICUs). The 144 consecutive patients admitted to ICUs and requiring mechanical ventilation for >48 hours were included. Smoking status was assessed at ICU admission by using the Fagerström Test of Nicotine Dependence (FTND). Agitation, with the Sedation-Agitation Scale (SAS), and delirium, with the Intensive Care Delirium Screening Checklist (ICDSC), were tested twice daily during the ICU stay. Agitation and delirium were defined by SAS >4 and ICDSC >4, respectively. Nosocomial complications and outcomes were evaluated.

Results: Smokers (n = 44) were younger and more frequently male and were more likely to have a history of alcoholism and to have septic shock as the reason for ICU admission than were nonsmokers. The incidence of agitation, but not delirium, increased significantly in the smoker group (64% versus 32%; P = 0.0005). Nicotine abstinence was associated with higher incidences of self-removal of tubes and catheters, and with more interventions, including the need for supplemental sedatives, analgesics, neuroleptics, and physical restraints. Sedation-free days, ventilator-free days, length of stay, and mortality in ICUs did not differ between groups. Multivariate analysis identified active smoking (OR, 3.13; 95% CI, 1.45-6.74; P = 0.003) as an independent risk factor for agitation. Based on a subgroup of 56 patients, analysis of 28 pairs of patients (smokers and nonsmokers in a 1:1 ratio) matched for age, gender, and alcoholism status found similar results regarding the role of nicotine withdrawal in increasing the risk of agitation during an ICU stay.

Conclusions: Nicotine withdrawal was associated with agitation and higher morbidities in critically ill patients. These results suggest the need to look specifically at those patients with tobacco dependency by using the FTND in ICU settings. Identifying patients at risk of behavioral disorders may lead to earlier interventions in routine clinical practice.

Figures

Figure 1
Figure 1
Flow chart of the patients admitted to the intensive care units (ICUs) during the study period. Center 1, Caen University Hospital; Center 2: Memorial St-Lô Hospital.

References

    1. Hatsukami DK, Stead LF, Gupta PC. Tobacco addiction. Lancet. 2008;371:2027–2038. doi: 10.1016/S0140-6736(08)60871-5.
    1. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA. 1990;264:1546–1549. doi: 10.1001/jama.264.12.1546.
    1. John U, Meyer C, Rumpf HJ, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity: a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004;76:287–295. doi: 10.1016/j.drugalcdep.2004.06.004.
    1. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tobacco Res. 2007;9:315–327. doi: 10.1080/14622200701188919.
    1. Piasecki TM, Fiore MC, McCarthy DE, Baker TB. Have we lost our way? The need for dynamic formulations of smoking relapse proneness. Addiction. 2002;97:1093–1108. doi: 10.1046/j.1360-0443.2002.00216.x.
    1. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med. 2008;168:1950–1960. doi: 10.1001/archinte.168.18.1950.
    1. Chevrolet JC, Jolliet P. Clinical review: agitation and delirium in the critically ill: significance and management. Crit Care. 2007;11:214. doi: 10.1186/cc5787.
    1. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med. 2001;27:1297–1304. doi: 10.1007/s001340101017.
    1. Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU) JAMA. 2001;286:2703–2710. doi: 10.1001/jama.286.21.2703.
    1. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753–1762. doi: 10.1001/jama.291.14.1753.
    1. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33:66–73. doi: 10.1007/s00134-006-0399-8.
    1. Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624–636. doi: 10.1378/chest.06-1795.
    1. Woods JC, Mion LC, Connor JT, Viray F, Jahan L, Huber C, McHugh R, Gonzales JP, Stoller JK, Arroliga AC. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med. 2004;30:1066–1072. doi: 10.1007/s00134-004-2193-9.
    1. Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med. 2007;35:1517–1521. doi: 10.1097/01.CCM.0000266537.86437.38.
    1. O'Connor PG, Schottenfeld RS. Patients with alcohol problems. N Engl J Med. 1998;338:592–602. doi: 10.1056/NEJM199802263380907.
    1. Saitz R. Clinical practice: unhealthy alcohol use. N Engl J Med. 2005;352:596–607. doi: 10.1056/NEJMcp042262.
    1. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–2963. doi: 10.1001/jama.270.24.2957.
    1. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710. doi: 10.1007/BF01709751.
    1. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656–659. doi: 10.1136/bmj.2.5920.656.
    1. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–1127. doi: 10.1111/j.1360-0443.1991.tb01879.x.
    1. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27:1325–1329. doi: 10.1097/00003246-199907000-00022.
    1. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27:859–864. doi: 10.1007/s001340100909.
    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, (DSM-IV) 4. Washington, DC: APA; 1994.
    1. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis: critical level of quantitative tip cultures. Arch Intern Med. 1987;147:873–877. doi: 10.1001/archinte.147.5.873.
    1. Girou E, Stephan F, Novara A, Safar M, Fagon JY. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998;157:1151–1158.
    1. Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF, Mann C, Lefrant JY, Eledjam JJ. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med. 2006;34:1691–1699. doi: 10.1097/01.CCM.0000218416.62457.56.
    1. Fraser GL, Prato BS, Riker RR, Berthiaume D, Wilkins ML. Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy. 2000;20:75–82. doi: 10.1592/phco.20.1.75.34663.
    1. Jaber S, Chanques G, Altairac C, Sebbane M, Vergne C, Perrigault PF, Eledjam JJ. A prospective study of agitation in a medical-surgical ICU: incidence, risk factors, and outcomes. Chest. 2005;128:2749–2757. doi: 10.1378/chest.128.4.2749.
    1. Devlin JW, Boleski G, Mlynarek M, Nerenz DR, Peterson E, Jankowski M, Horst HM, Zarowitz BJ. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999;27:1271–1275. doi: 10.1097/00003246-199907000-00008.
    1. Migon MN, Coutinho ES, Huf G, Adams CE, Cunha GM, Allen MH. Factors associated with the use of physical restraints for agitated patients in psychiatric emergency rooms. Gen Hosp Psychiatry. 2008;30:263–268. doi: 10.1016/j.genhosppsych.2007.12.005.
    1. Hine K. The use of physical restraint in critical care. Nurs Crit Care. 2007;12:6–11. doi: 10.1111/j.1478-5153.2006.00197.x.
    1. Milbrandt EB, Kersten A, Kong L, Weissfeld LA, Clermont G, Fink MP, Angus DC. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 2005;33:226–229. doi: 10.1097/01.CCM.0000150743.16005.9A. discussion 263-225.
    1. Freeman BD, Dixon DJ, Coopersmith CM, Zehnbauer BA, Buchman TG. Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf. 2008;17:971–981. doi: 10.1002/pds.1637.
    1. Joseph AM, Norman SM, Ferry LH, Prochazka AV, Westman EC, Steele BG, Sherman SE, Cleveland M, Antonuccio DO, Hartman N, McGovern PG. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1792–1798. doi: 10.1056/NEJM199612123352402.
    1. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004. p. CD000146.
    1. Gourlay SG, Stead LF, Benowitz NL. Clonidine for smoking cessation. Cochrane Database Syst Rev. 2004. p. CD000058.
    1. Reade MC, O'Sullivan K, Bates S, Goldsmith D, St Ainslie WR, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care. 2009;13:R75. doi: 10.1186/cc7890.
    1. Dubin WR, Field HL, Gastfriend DR. Postcardiotomy delirium: a critical review. J Thorac Cardiovasc Surg. 1979;77:586–594.
    1. Lat I, McMillian W, Taylor S, Janzen JM, Papadopoulos S, Korth L, Ehtisham A, Nold J, Agarwal S, Azocar R, Burke P. The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med. 2009;37:1898–1905. doi: 10.1097/CCM.0b013e31819ffe38.
    1. Micek ST, Anand NJ, Laible BR, Shannon WD, Kollef MH. Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med. 2005;33:1260–1265. doi: 10.1097/.
    1. Mayer SA, Chong JY, Ridgway E, Min KC, Commichau C, Bernardini GL. Delirium from nicotine withdrawal in neuro-ICU patients. Neurology. 2001;57:551–553.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다